INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 425m ago
HOUSE PTR25m ago
SEC 13F24m ago
ROBINHOOD CHAIN24m ago
RM
Corporate insider

Robins Chad M

Director, CEO and ChairmanCIK 0001780649

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 5
Max Insider Score32
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
25
RM
Robins Chad MDirector, CEO and Chairman
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$1.20M
83.3K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Adaptive Biotechnologies CorpDirector, CEO and Chairman · Dec 1, 2025
22
RM
Robins Chad MDirector, CEO and Chairman
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL
$566K
37.3K sh
Apr 8, 2026
Apr 8, 2026
traded Apr 8, 2026
+0d
SEC FORM 4

Evidence

25
RM
Robins Chad MDirector, CEO and Chairman
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$1.95M
125.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

32
RM
Robins Chad MDirector, CEO and Chairman
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$703K
35.7K sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC FORM 4

Evidence

25
RM
Robins Chad MDirector, CEO and Chairman
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$2.37M
125.0K sh
Dec 1, 2025Dec 1, 2025
traded Dec 1, 2025
+0dSEC FORM 4

Evidence